Summerset Group sees 26% rise in full-year sales

Summerset Group (ASX:SNZ) recorded 448 sales for the quarter ended Dec. 31, 2025, consisting of 207 new sales and 241 resales, capping a full-year total of 1,560 settlements—up 26 percent from FY24.

The annual result included 125 care bed conversions as the company continued transitioning care beds to occupation right agreements.

Excluding these conversions, new sales reached 680, a 16 percent increase from 588 in FY24.

CEO Scott Scoullar said the company was pleased with the continued sales momentum. "This is a positive result reflecting our hard work to attract new residents and improve care profitability. Achieving both a record quarter and full-year performance in a challenging market is very encouraging," he said.

Top-performing villages for new sales in the quarter included Summerset Boulcott, Summerset by the Dunes Pāpāmoa, Summerset St Johns, and Summerset Pohutukawa Place.

Resales also finished the year strongly, with only 2.7% of the portfolio uncontracted, down from 3% at FY24.

During FY25, Summerset delivered 637 units in New Zealand and 56 in Australia, meeting its target range of 600–650 and 50–80 units, respectively.

The company closed the year with a 31% increase in contracted new-sale stock over the past 12 months, while uncontracted stock remained stable.

At the time of reporting, Summerset Group's share price was $10.11.